Homeβ€ΊSearchβ€ΊJournal of Pharmaceutical Policy and Practice

Journal of Pharmaceutical Policy and Practice

Taylor and Francis Ltd. Β· United Kingdom Β· Est. 2005

ISSN2052-3211eISSN2052-3211
SJR Q1βœ“ WOS ESCIβœ“ Scopus / SJRβœ“ DOAJβœ“ Open Access
100
/ 100
High Trust
PubScope credibility score from verifiable indexing & ethics signals
Score Breakdown
β—† Scopus Q178
βœ“ Corroboration (4 more)+22
Total100
Level data: Norwegian Register (HK-dir), NLOD 2.0. Β· Third-party records Β· how this is calculated Β· Report an error β†’
⚑ Speed vs Prestige
How does this journal balance review speed with impact level?
178
days submission β†’ published
measured Β· last 19 articles Β· accept 141d
14
weeks to publish Β· journal-reported
Average Β· vs ~15 wk median
Q1
SJR Rank
Top 25% in field
Impact Factor & Quartile Β· Web of Science (JCR)

βœ“ Indexed in the Web of Science Core Collection (ESCI) β€” Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page β†—

The Impact Factor & JCR quartile are licensed by Clarivate β€” we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

SJR Scorei
0.74
H-Indexi
49
CiteScore
ViewΒ β†—
Scopus metric Β· on the journal’s page
SNIPi
1.014
Total Worksi
1,102
Total Citationsi
13,654
2yr Mean Citednessi
2.34
Open Impact Factor alternative

Aims & Scope

Subject areas: Health Policy & Services; Pharmacology & Pharmacy; Pharmacology, Toxicology and Pharmaceutics (miscellaneous); Pharmacy; Health Policy.

General Information

Country / RegionUnited Kingdom
Primary LanguageEnglish
1st Year Published2005
Annual Volume~ 155 articles / year
StatusActive (last: 2026)
Total Publications1,102
Publisher OrgBioMed Central
OA Since2013
Visit Journal Website

Submission Info

Peer ReviewDouble-blind
Review Time~14 weeks
Acceptance Rateβ€”
OA LicenseCC BY, CC BY-NC
OA Rateβ€”

Ethics & Quality

COPE Memberβœ— No
OASPA Memberβœ— No
Not on Predatory Listsβœ“ Yes
Plagiarism Detectionβœ“ Yes
πŸ“¦ Long-term Preservation
ChinaCLOCKSSLOCKSSPorticoNational Digital Preservation Program

Think.Check.Submit Compliance

10/12 Β· 83%
βœ…
Do you know the journal / publisher?
Taylor and Francis Ltd.
βœ…
Does the journal have a website?
βœ“ Linked
βœ…
Is the ISSN verified?
2052-3211 / 2052-3211
βœ…
Indexed in a trusted database?
WoS, Scopus, DOAJ, PubMed
βœ…
Peer review process documented?
Double-blind
❌
Follows ethical publishing standards (COPE)?
N/A
❌
APC fees clearly disclosed?
N/A
βœ…
Not on predatory/blacklists?
βœ“ Clean
βœ…
Long-term digital preservation?
China, CLOCKSS, LOCKSS, Portico, National Digital Preservation Program
βœ…
Plagiarism detection in place?
Yes
βœ…
Listed in DOAJ (verified OA)?
DOAJ verified
βœ…
Primary language documented?
English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Citations received
37
903
2019
76
2.3k
2020
115
2.4k
2021
107
1.7k
2022
186
1.7k
2023
131
602
2024
149
398
2025
75
8
2026

Source: OpenAlex Β· Each year’s green bar = citations earned by that year’s papers, counted to date β€” so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category β€” its quartile can differ by discipline.

Pharmacology, Toxicology and Pharmaceutics (miscellaneous)Q1
PharmacyQ1
Health PolicyQ2

Subject Classification

Web of Science Categories

Health Policy & ServicesPharmacology & Pharmacy

Scopus Categories

PharmacyHealth PolicyPharmacology, Toxicology and Pharmaceutics (miscellaneous)

Research Topics (OpenAlex)

Pharmaceutical Economics and PolicyPharmaceutical Practices and Patient OutcomesAntibiotic Use and ResistancePharmaceutical Quality and CounterfeitingHealth Systems, Economic Evaluations, Quality of LifeMedication Adherence and CompliancePharmaceutical studies and practicesPharmacovigilance and Adverse Drug ReactionsHealthcare Systems and ReformsGlobal Maternal and Child Health

Frequently asked questions about Journal of Pharmaceutical Policy and Practice

Is Journal of Pharmaceutical Policy and Practice a predatory journal?

PubScope has no integrity flags on record for Journal of Pharmaceutical Policy and Practice: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 100/100. Indexing is a transparency signal, not a guarantee β€” always confirm fit and policies before submitting.

What is the impact factor of Journal of Pharmaceutical Policy and Practice?

Journal of Pharmaceutical Policy and Practice is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal β€” including Arts & Humanities and Emerging Sources titles β€” receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 2.34.

Is Journal of Pharmaceutical Policy and Practice indexed in Scopus and Web of Science?

Journal of Pharmaceutical Policy and Practice is indexed in Web of Science, Scopus, DOAJ.

What is the aims and scope of Journal of Pharmaceutical Policy and Practice?

Subject areas: Health Policy & Services; Pharmacology & Pharmacy; Pharmacology, Toxicology and Pharmaceutics (miscellaneous); Pharmacy; Health Policy.

Compare This JournalFind Similar← Back to Search
Understand these signals
How to tell if a journal is predatoryWhat Q1–Q4 quartiles meanWeb of Science vs Scopus vs DOAJWhat is an APC?

Data updated: 2026-05-22 Β· Sources: SJR, DOAJ, OpenAlex, WoS, Crossref